Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series
Open Access
- 13 April 2020
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 8 (7) , 1126-1129
Abstract
Two patients with normal renal function, yet each showed unexpected, supra‐ and subtherapeutic linezolid plasma concentrations resulting in toxicity and ineffective therapy, respectively. TDM helps to early identify and correct such excursions.Keywords
This publication has 9 references indexed in Scilit:
- Clinical Pharmacokinetics and Pharmacodynamics of OxazolidinonesClinical Pharmacokinetics, 2017
- A 10‐Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital‐wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?Basic & Clinical Pharmacology & Toxicology, 2017
- Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoringJournal of Infection and Chemotherapy, 2016
- Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinonesExpert Opinion on Drug Metabolism & Toxicology, 2016
- Pharmacokinetics of high dosage of linezolid in two morbidly obese patientsJournal of Antimicrobial Chemotherapy, 2015
- Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infectionsInternational Journal of Antimicrobial Agents, 2013
- Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly PatientsThe Journal of Clinical Pharmacology, 2009
- Linezolid absolute bioavailability and the effect of food on oral bioavailabilityBiopharmaceutics & Drug Disposition, 2001
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976